Suppr超能文献

卵巢癌的当前管理策略。

Current management strategies for ovarian cancer.

作者信息

Aletti Giovanni D, Gallenberg Mary M, Cliby William A, Jatoi Aminah, Hartmann Lynn C

机构信息

Division of Gynecologic Surgery, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.

出版信息

Mayo Clin Proc. 2007 Jun;82(6):751-70. doi: 10.4065/82.6.751.

Abstract

Epithelial ovarian cancer originates in the layer of cells that covers the surface of the ovaries. The disease spreads readily throughout the peritoneal cavity and to the lymphatics, often before causing symptoms. Of the cancers unique to women, ovarian cancer has the highest mortality rate. Most women are diagnosed as having advanced stage disease, and efforts to develop new screening approaches for ovarian cancer are a high priority. Optimal treatment of ovarian cancer begins with optimal cytoreductive surgery followed by combination chemotherapy. Ovarian cancer, even in advanced stages, is sensitive to a variety of chemotherapeutics. Although improved chemotherapy has increased 5-year survival rates, overall survival gains have been limited because of our inability to eradicate all disease. Technologic advances that allow us to examine the molecular machinery that drives ovarian cancer cells have helped to identify numerous therapeutic targets within these cells. In this review, we provide an overview of ovarian cancer with particular emphasis on recent advances in operative management and systemic therapies.

摘要

上皮性卵巢癌起源于覆盖卵巢表面的细胞层。该疾病常常在出现症状之前就很容易扩散至整个腹腔和淋巴管。在女性特有的癌症中,卵巢癌的死亡率最高。大多数女性被诊断为晚期疾病,因此开发新的卵巢癌筛查方法成为当务之急。卵巢癌的最佳治疗始于最佳的细胞减灭术,随后进行联合化疗。卵巢癌即使处于晚期,对多种化疗药物也敏感。尽管化疗的改进提高了5年生存率,但由于我们无法根除所有疾病,总体生存获益仍然有限。能够让我们研究驱动卵巢癌细胞的分子机制的技术进步,有助于在这些细胞中识别出众多治疗靶点。在本综述中,我们概述了卵巢癌,特别强调了手术治疗和全身治疗方面的最新进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验